Skip to content
10-Q

Quarterly Report

ZYNERBA PHARMACEUTICALS, INC.

0001558370-22-017583

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 9, 2022 47.06M sh
Shares Diluted Q3 2022 · Sep 30, 2022 43.75M sh
Shares Diluted Q3 2022 · Sep 30, 2022 41.83M sh
Shares Diluted Q3 2022 · Sep 30, 2021 40.09M sh
Shares Diluted Q3 2022 · Sep 30, 2021 38.93M sh
Capex Q3 2022 · Sep 30, 2022 $146.71K
Capex Q3 2022 · Sep 30, 2021 $47.57K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$17.34M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$25.62M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $55.93M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $67.81M
Stockholders Equity Q3 2022 · Sep 30, 2022 $52.76M
Stockholders Equity Q3 2022 · Jun 30, 2022 $57.24M
Stockholders Equity Q3 2022 · Mar 31, 2022 $65.17M
Stockholders Equity Q3 2022 · Dec 31, 2021 $70.91M
Stockholders Equity Q3 2022 · Sep 30, 2021 $78.69M
Stockholders Equity Q3 2022 · Jun 30, 2021 $87.7M
Stockholders Equity Q3 2022 · Mar 31, 2021 $95.71M
Stockholders Equity Q3 2022 · Dec 31, 2020 $60.14M
Current Liabilities Q3 2022 · Sep 30, 2022 $9.43M
Current Liabilities Q3 2022 · Dec 31, 2021 $9.9M
Total Liabilities Q3 2022 · Sep 30, 2022 $9.61M
Total Liabilities Q3 2022 · Dec 31, 2021 $10.26M
Current Assets Q3 2022 · Sep 30, 2022 $60.8M
Current Assets Q3 2022 · Dec 31, 2021 $80.22M
Total Assets Q3 2022 · Sep 30, 2022 $62.37M
Total Assets Q3 2022 · Dec 31, 2021 $81.17M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.20
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.65
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.26
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.73
Eps Basic Q3 2022 · Sep 30, 2022 −$0.20
Eps Basic Q3 2022 · Sep 30, 2022 −$0.65
Eps Basic Q3 2022 · Sep 30, 2021 −$0.26
Eps Basic Q3 2022 · Sep 30, 2021 −$0.73
Sga Expense Q3 2022 · Sep 30, 2022 $3.45M
Sga Expense Q3 2022 · Sep 30, 2022 $10.93M
Sga Expense Q3 2022 · Sep 30, 2021 $3.87M
Sga Expense Q3 2022 · Sep 30, 2021 $11.53M
Rd Expense Q3 2022 · Sep 30, 2022 $5.04M
Rd Expense Q3 2022 · Sep 30, 2022 $15.63M
Rd Expense Q3 2022 · Sep 30, 2021 $6.34M
Rd Expense Q3 2022 · Sep 30, 2021 $16.4M
Net Income Q3 2022 · Sep 30, 2022 −$8.68M
Net Income Q3 2022 · Jun 30, 2022 −$9.85M
Net Income Q3 2022 · Mar 31, 2022 −$8.49M
Net Income Q3 2022 · Sep 30, 2021 −$10.58M
Net Income Q3 2022 · Jun 30, 2021 −$9.95M
Net Income Q3 2022 · Mar 31, 2021 −$7.96M
Operating Income Q3 2022 · Sep 30, 2022 −$8.49M
Operating Income Q3 2022 · Sep 30, 2022 −$26.57M
Operating Income Q3 2022 · Sep 30, 2021 −$10.21M
Operating Income Q3 2022 · Sep 30, 2021 −$27.93M